Atherosclerosis and Coenzyme Q₁₀

Area of Science:

• Cardiovascular Science
• Biochemistry
• Aging Research

Background:

• Atherosclerosis is a leading cause of global cardiac mortality, traditionally viewed as arterial lipid deposition.
• Cellular factors including inflammation, impaired autophagy, mitochondrial dysfunction, and oxidative stress significantly contribute to arterial damage.

Purpose of the Study:

• To review the current understanding of coenzyme Q10 (CoQ10) in relation to atherosclerosis.
• To explore CoQ10's potential as a therapeutic agent for atherosclerosis and age-related conditions.

Main Methods:

• Literature review focusing on the molecular and cellular mechanisms of atherosclerosis.
• Analysis of CoQ10's biochemical properties and their relevance to pathological pathways in atherosclerosis.
• Exploration of the link between atherosclerosis, aging, and CoQ10 supplementation.

Main Results:

• CoQ10 possesses multifunctional properties, including redox and signaling capabilities.
• CoQ10 may counteract key cellular dysfunctions implicated in atherosclerosis, such as cholesterol biosynthesis issues, autophagy impairment, and mitochondrial dysfunction.
• Atherosclerosis shares phenotypic similarities with aging, suggesting CoQ10 could benefit both.

Conclusions:

• CoQ10 presents a promising therapeutic candidate for atherosclerosis due to its ability to address multiple cellular pathologies.
• Supplementation with CoQ10 may hold potential benefits for managing both atherosclerosis and the aging process.